PIONEERING BIOSIMILARS Trademark

Trademark Overview

On Wednesday, September 2, 2015, a trademark application was filed for PIONEERING BIOSIMILARS with the United States Patent and Trademark Office. The USPTO has given the PIONEERING BIOSIMILARS trademark a serial number of 86745508. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, February 25, 2019. This trademark is owned by Novartis AG. The PIONEERING BIOSIMILARS trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Providing health information; Providing medical information
pioneering biosimilars

General Information

Serial Number86745508
Word MarkPIONEERING BIOSIMILARS
Filing DateWednesday, September 2, 2015
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, February 25, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 24, 2015

Trademark Statements

Goods and ServicesProviding health information; Providing medical information
Pseudo MarkPIONEERING BIO SIMILARS

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, September 8, 2015
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBasel
CH
Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBasel
CH

Trademark Events

Event DateEvent Description
Monday, February 25, 2019ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, February 25, 2019ABANDONMENT - NO USE STATEMENT FILED
Saturday, July 21, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, July 20, 2018EXTENSION 5 GRANTED
Saturday, July 14, 2018EXTENSION 5 FILED
Friday, July 20, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Saturday, July 14, 2018TEAS EXTENSION RECEIVED
Saturday, January 20, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 18, 2018EXTENSION 4 GRANTED
Thursday, January 18, 2018EXTENSION 4 FILED
Thursday, January 18, 2018TEAS EXTENSION RECEIVED
Tuesday, July 11, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, July 8, 2017EXTENSION 3 GRANTED
Saturday, July 8, 2017EXTENSION 3 FILED
Saturday, July 8, 2017TEAS EXTENSION RECEIVED
Thursday, January 19, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 17, 2017EXTENSION 2 GRANTED
Tuesday, January 17, 2017EXTENSION 2 FILED
Tuesday, January 17, 2017TEAS EXTENSION RECEIVED
Saturday, July 16, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 14, 2016EXTENSION 1 GRANTED
Thursday, July 14, 2016EXTENSION 1 FILED
Thursday, July 14, 2016TEAS EXTENSION RECEIVED
Tuesday, January 19, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 24, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 24, 2015PUBLISHED FOR OPPOSITION
Wednesday, November 4, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 20, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, October 20, 2015ASSIGNED TO EXAMINER
Wednesday, September 9, 2015NOTICE OF PSEUDO MARK E-MAILED
Tuesday, September 8, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, September 5, 2015NEW APPLICATION ENTERED IN TRAM

Related Keywords

biosimilars pioneering information providing medical health